Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01
Clinical trial NCT07290894 · RECRUITING
Trial details
- NCT number
- NCT07290894
- Sponsor
- National Cancer Institute, Naples
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-12
- Primary completion
- 2031-10-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.